Solid lipid microparticles for the stability enhancement of the polar drug N6-cyclopentyladenosine

被引:13
作者
Dalpiaz, A. [1 ]
Mezzena, M. [1 ]
Scatturin, A. [1 ]
Scalia, S. [1 ]
机构
[1] Univ Ferrara, Dept Pharmaceut Sci, I-44100 Ferrara, Italy
关键词
controlled release; N-6-cyclopentyladenosine; solid lipid microparticles; stability in blood; stearic acid; polar drug encapsulation;
D O I
10.1016/j.ijpharm.2007.11.044
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The objective of this study was to prepare solid lipid microparticles (SLMs) loaded with the polar adenosine A(1) receptor agonist N-6-cyclopentyladenosine (CPA). The microparticles were produced by the conventional hot emulsion technique, using different lipidic carriers (tristearin, glyceryl behenate and stearic acid) and hydrogenated phosphatidylcholine as the surfactant. The controlled release of CPA was achieved only with stearic acid microparticles. This phenomenon has been attributed to direct acid-base interactions between the basic nitrogen atoms of CPA and stearic acid. These SLMs were characterized by release studies, scanning electron microscopy and powder X-ray diffraction analyses. The obtained particles showed proper features in terms of morphology and size distribution (3.2-10.3 mu m), with a drug loading of 0.15 +/- 0.04%. The influence of the SLMs carrier system on CPA stability was investigated in vitro using human whole blood. The degradation kinetic of microparticle-entrapped CPA was significantly lower from that measured for the free CPA. The overall results indicate that it was possible to achieve the encapsulation and controlled release of a polar drug, such as CPA, within a lipid matrix without resorting to the complex methods generally used for the preparation of these systems. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:81 / 86
页数:6
相关论文
共 31 条
[1]  
Bloomfield VA, 2000, NUCL ACIDS STRUCTURE
[2]   PROCESS AND FORMULATION VARIABLES IN THE PREPARATION OF WAX MICROPARTICLES BY A MELT DISPERSION TECHNIQUE .2. W/O/W MULTIPLE EMULSION TECHNIQUE FOR WATER-SOLUBLE DRUGS [J].
BODMEIER, R ;
WANG, J ;
BHAGWATWAR, H .
JOURNAL OF MICROENCAPSULATION, 1992, 9 (01) :99-107
[3]   CENTRAL VERSUS PERIPHERAL MEDIATION OF RESPONSES TO ADENOSINE RECEPTOR AGONISTS - EVIDENCE AGAINST A CENTRAL MODE OF ACTION [J].
BRODIE, MS ;
LEE, K ;
FREDHOLM, BB ;
STAHLE, L ;
DUNWIDDIE, TV .
BRAIN RESEARCH, 1987, 415 (02) :323-330
[4]   Novel sustained release microspheres for pulmonary drug delivery [J].
Cook, RO ;
Pannu, RK ;
Kellaway, IW .
JOURNAL OF CONTROLLED RELEASE, 2005, 104 (01) :79-90
[5]   Production of lipospheres as carriers for bioactive compounds [J].
Cortesi, R ;
Esposito, E ;
Luca, G ;
Nastruzzi, C .
BIOMATERIALS, 2002, 23 (11) :2283-2294
[6]   Developement and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives [J].
Dalpiaz, A ;
Leo, E ;
Vitali, F ;
Pavan, B ;
Scatturin, A ;
Bortolotti, F ;
Manfredini, S ;
Durini, E ;
Forni, F ;
Brina, B ;
Vandelli, MA .
BIOMATERIALS, 2005, 26 (11) :1299-1306
[7]   Poly(lactic acid) microspheres for the sustained release of antiischemic agents [J].
Dalpiaz, A ;
Scatturin, A ;
Pavan, B ;
Biondi, C ;
Vandelli, MA ;
Forni, F .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 242 (1-2) :115-120
[8]   Adenosine A1 receptor:: Analysis of the potential therapeutic effects obtained by its activation in the central nervous system [J].
Dalpiaz, A ;
Manfredini, S .
CURRENT MEDICINAL CHEMISTRY, 2002, 9 (21) :1923-1937
[9]   Synthesis and study of 5′-ester prodrugs of N6-cyclopentgladenosine, a selective A1 receptor agonist [J].
Dalpiaz, A ;
Scatturin, A ;
Menegatti, E ;
Bortolotti, F ;
Pavan, B ;
Biondi, C ;
Durini, E ;
Manfredini, S .
PHARMACEUTICAL RESEARCH, 2001, 18 (04) :531-536
[10]   Poly(lactic acid) microspheres for the sustained release of a selective A1 receptor agonist [J].
Dalpiaz, A ;
Scatturin, A ;
Pavan, B ;
Biondi, C ;
Vandelli, MA ;
Forni, F .
JOURNAL OF CONTROLLED RELEASE, 2001, 73 (2-3) :303-313